Objective To assess the quality of Cochrane reviews.
Introduction
In the late 1980s clinicians drew attention to the poor scientific quality of healthcare review articles. [1] [2] [3] Subsequently, the need for systematic reviews of the effects of healthcare interventions has been widely recognised and checklists and guidelines have been developed. [4] [5] [6] The Cochrane Collaboration has led the way in setting new standards for preparing systematic reviews, 4 which are published in electronic format (CD Rom issued quarterly) as part of the Cochrane Library. In contrast, few conventional medical journals provide specific guidelines for authors of systematic reviews. 7 Cochrane reviews should therefore be expected to use higher quality methods and should be less prone to bias than systematic reviews published in traditional medical journals. These expectations have been confirmed by four comparative studies of quality and one of bias. [8] [9] [10] [11] [12] However, there is always room for improvement. All scientific reports, including Cochrane reviews, should be read critically. Errors occur, and potential biases may emerge. The comments and criticisms (electronic "letters to the editor" linked to the relevant review) published in the Cochrane Library and the ensuing changes show that some Cochrane reviews have needed correction and improvement.
A group of Cochrane methodologists collaborated to critically read a sample of Cochrane reviews in order to identify and characterise the most common methodological problems. We expected that Cochrane reviews would fulfil most of the criteria that were listed in the current version of the Cochrane handbook 4 and in relevant checklists, so we used a semistructured approach that allowed the assessors to note all kinds of problems they encountered. Our aim was to identify the aspects of Cochrane reviews that are most in need of improvement.
Methods
During the 1998 Cochrane Colloquium the lead researcher (OO) contacted 11 methodologists with various Cochrane affiliations, who subsequently volunteered to assess the methodological quality of the 53 reviews first published in issue 4 of the Cochrane Library in 1998.
w1-w53 The project was carried out in 1999 and was coordinated by the Nordic Cochrane Centre. Each review was independently examined by two assessors. We allocated the reviews to assessors by assigning a random number to each review, sorting the numbers in ascending order, and linking the sorted list to a prespecified list of the 55 possible pairs of assessors. Each assessor was assigned nine or 10 reviews, and this assignment was not subsequently changed.
We gave a letter A-E to the overall assessment for each review: A indicated no problems, B minor problems, C major problems, D lack of clarity, and E other types of comments (box 1). We collected and tabulated the individual scores at the Nordic Cochrane Centre. If one of the assessors had noted a major problem in a review, the two assessors decided whether to give feedback to the reviewers and editors by using the comments and criticisms system in the Cochrane Library. The lead researcher also used submitted comments and criticisms to identify common types of problems. This paper focuses on reviews that had major problems.
Results
One of the 11 methodologists withdrew from the project, and a few assessors did not manage to assess all of their allotted reviews. We initially received 91 (86%) sets of comments out of the expected 106; these related to 52 of the 53 reviews. The review that had not been assessed was removed from the analysis. Three assessors subsequently volunteered to read additional reviews, so that two people assessed any review in which a major problem had been identified.
The scores given in the 91 independent assessments were A, 24; B, 31; C, 19; D, 10; AB, 3; BD, 3; and DE, 1. The number of A scores (indicating no problems) given by individual assessors ranged from 0 to 6, with a median of 2, out of a possible maximum of 10. The number of C scores (major problems) ranged from 0 to 4, also with a median of 2 (table 1) .
Of the 52 reviews, 39 (75%) were assessed independently by two reviewers (table 2) . Pairs of assessors agreed completely for 13 (33%) reviews; they gave assessments in adjacent categories (A and B or B and C) for 14 (34%). Two (5%) reviews had contradictory assessments (A and C); for each of the remaining 10 (28%) reviews, one of the assessors felt it lacked clarity (D). The 13 reviews assessed by only one reviewer obtained the following scores: A, 1; AB, 2; B, 7; and C, 3. Nineteen (37%) of the 52 reviews had at least one A score, and 17 (33%) had at least one C score.
Pairs of assessors reached agreement on 13 comments and criticisms, which both reviewers wrote jointly; for various reasons an additional four were contributed by only one assessor (one additional assessor withdrew from the project). The full texts of the submitted comments and criticisms are on the BMJ's website.
While classifying the comments and criticisms, we discovered that for two reviews the assessors seemed to have agreed on a C by mistake, leaving 15 reviews (29%, 95% confidence interval 17% to 43%) with major problems. There were three areas of concern. Firstly, the evidence did not support the conclusions in nine (17%) reviews (table 3) . Secondly, the conduct or reporting of the reviews was unsatisfactory in 12 (23%) reviews (box 2). Thirdly, there were stylistic concerns with 12 (23%) reviews.
The problematic conclusions all described the effect of the experimental treatment in terms that we judged to have been too optimistic (table 3) . None of these nine reviews indicated a bias towards the control treatment.
The most common problems with methods (box 2) concerned inclusion and exclusion of trials (six reviews), concealment of allocation (five), loss to follow up (four), choice of outcome measures (four), and statistics (three). Other problems were found only oncefor example, a conclusion based largely on a single trial that seemed to have major weaknesses. Stylistic problems were indicated by statements such as "many spelling and grammatical errors," "a few typographical errors," "seems to be an unfinished draft," "needs to be edited to be more readable and comprehensible." Four reviews had many spelling and typographical errors, and these four also had problems relating to their methods and conclusions.
Discussion
Fifteen (29%) of 52 Cochrane reviews first published in 1998 were judged to have major problems, among which biased conclusions, problems with methods, and insufficient typographical or stylistic editing were the most common. Thus, even though Cochrane reviews Box 1: Assessment format-the assessors were asked to choose one option for each review and give details as appropriate A I encountered no problems in the review. I would be proud to show this review as an example of a Cochrane review B I encountered minor problems in the review-namely, the following: . . . C I encountered major problems in the review, and I think it deserves a comment and criticism along the lines of . . . D The review might be OK, but I need clarification on . . . E Any other unstructured comments are based on specific guidelines 4 and have higher quality methods on average than systematic reviews published in conventional journals, [8] [9] [10] [11] problems were still common. The problems we identified in these reviews were brought to the attention of their authors through the electronic comments and criticism system; revised versions of some reviews have subsequently appeared in the Cochrane Library (in some instances with a changed title), and other revisions are being prepared.
Strengths and weaknesses of the study
We studied Cochrane reviews that were first published nearly three years ago. A range of quality initiatives has been implemented by the Cochrane Collaboration since then; we hope that a study of current Cochrane reviews would reveal a smaller proportion of reviews with major problems.
Assessing only reviews first published in issue 4 of the Cochrane Library in 1998 was a decision of convenience and may have led to a sample that was not representative of all the Cochrane reviews available at that time. For example, if these new reviews had been contributed mainly by relatively inexperienced reviewers and editorial groups, our overall findings may have overestimated the proportion of reviews with major problems. On the other hand, even in 1998, three years after the first Cochrane reviews had been published, new reviews might be expected to have been of higher quality than older reviews, thus leading to a bias in the opposite direction.
Our individual assessments were done in a semistructured way, without a checklist, by experienced, selected volunteer methodologists from the Cochrane Collaboration, who were advised to spend not more than 10 hours in total on the exercise. The time constraint and lack of a checklist may have led to some errors going undetected. Conversely, the use of experienced methodologists may have led to detection of unexpected errors. The way assessors were recruited may have led us to be particularly mild or particularly hard in our assessments. Because agreement was reached on most assessments, disagreements in the individual assessments probably reflected oversights by one of the assessors rather than true disagreement. On the other hand, four of the 15 comments and criticisms that were submitted had been written by only one assessor. Thus the number of identified problems might be an underestimate. Alternatively, the high number of problems described as major may partly reflect a few very demanding assessors. The fact that agreements were reached despite the variability in individual assessments indicates that selection of another set of methodologically trained assessors would probably not have greatly altered the final assessments. Treatment X "is associated with a reduction in death or oxygen requirement" w53 "Significant reduction was seen only for the combined outcome, not for death or reduction in oxygen requirement separately" "There is evidence to support the early use of X in disease Y" w47 "This conclusion . . .is unwarranted and misleading" as "the review might concern disease Z" (which is known to respond to treatment X) "X is associated with short term improvements" w29 "Given the limitations of the included studies we would recommend that the conclusions be modified to be more cautious"
"There are too few data to draw any reliable conclusions" w50 "Potential adverse effect is so important that it should be mentioned in the conclusions"
Box 2: Some examples of problems with methods
Inclusion and exclusion criteria were not well defined, w31,w51 inconsistently transferred from title to methods section (another category of patients or another type of intervention), w9,w31 or applied inconsistently, w31 subjectively, w29 or with retrospective rationalisation. w27 The problems partly related to choice of terminology-for example, "experimental or quasi-experimental designs" (meaning randomised or quasi-randomised or non-randomised studies?) resulting in different interpretations or enumerations in the "selection criteria," "description of studies," "main results," meta-analytic graphs, and "table of included studies" and in conflicting numbers w31,w51
Concealment of allocation was mixed up with double blinding, w4,w20,w29,w31 or discrepancies existed between the quality of the trials as described in the table of included trials, the graphs, and the main text.
w31,w52
These problems may occur much more often than we found as most occurrences were noted by a single assessor Assessors were particularly concerned about loss to follow up when rates of dropout were high (29%, 43%, 50%), w29,w51 dropouts were treatment failures, w29 or the reviewers claimed to have performed an intention to treat analysis but the numbers on the graphs did not fit with the number of included patients w52 ; the assessors asked for subgroup analyses including only trials with full follow up, more thorough documentation and discussion of loss to follow up, w4 One person (OO), while reading the 17 comments, created the three categories by grouping the problems identified. No hypotheses regarding these categories were stated at the outset. Prespecified categories and two data extractors would have strengthened the validity of the findings.
Relation to other studies of bias
Empirical studies have identified several important biases, such as publication bias and bias related to poor randomisation, related to individual trials that all tend to exaggerate the estimated beneficial effects of new treatments. [13] [14] [15] Important bias also arises in the step from results to conclusions. In a study of 196 drug trials, bias in the conclusions or abstracts favoured the new drug in 81 of 82 reports. 16 In accordance with these findings, the bias we found favoured the experimental treatment in all of the nine reviews with problematic conclusions. Thus the same type of bias seems to occur in the conclusions of systematic reviews as in reports of trials. This bias in systematic reviews, which is unrelated to bias in the individual trials, seems not to have been reported before. However, although dubious or invalid statements were found in 76% of the conclusions or abstracts of drug trial reports, 16 they occurred in only 17% of the Cochrane reviews.
Steps to improve quality Solutions to most of the methodological problems we met were described in the Cochrane handbook and other checklists for systematic reviews. 4 17 This indicates the need for better use of guidelines in scientific editing and peer review. The conclusion bias we observed has led to improved advice on how to write conclusions in Cochrane reviews in the most recent version of the Cochrane reviewers' handbook. 18 Since 1998 the Cochrane Collaboration has taken several additional steps to improve the quality of its reviews. A quality advisory group has been established and the post of quality improvement manager has been created. The Cochrane reviewers' handbook is improved regularly, and tools for assessing the quality of reviews are being developed. Several new courses for reviewers, statisticians, and editors have been developed, and two centralised editing projects are running. It is also important that users of the Cochrane Library participate in the process by submitting any relevant comments and criticisms they might have.
Implications for clinicians and policymakers
Seekers of the best available evidence on treatment and prevention should continue to look to the Cochrane Library as a key source of information, despite the deficiencies that we found in a minority of Cochrane reviews in the 1998 sample. Reliance on unsystematic reviews, textbooks, and anecdotal evidence is likely to be far more problematic. 1 19 No matter which sources of evidence are being used, users of the evidence need to learn the skills of critical appraisal. Guides and courses on critical appraisal are now widely accessible. 20 As with any scientific report, readers should themselves assess the reliability of individual Cochrane reviews. They should be particularly cautious of reviews with conclusions that favour experimental interventions when relatively little evidence is available for the review and of reviews with many typographical errors.
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What is already known on this topic Cochrane reviews are, on average, more systematic and less biased than systematic reviews published in paper journals Errors and biases also occur in Cochrane reviews
What this study adds
Too often, reviewers' conclusions over-rated the benefits of new interventions Readers of Cochrane reviews should remain cautious, especially regarding conclusions that favour new interventions
The Cochrane Collaboration has taken steps to improve the quality of reviews
